Mar 5 2010
Eleme Medical Inc. and Osyris Medical USA announced today that they have entered into a strategic co-marketing alliance. The companies will be collaborating on specific marketing, public relations and trade show events to target dermatologists, plastic surgeons and medical spas.
A recent MEDACorp survey of dermatologists and plastic surgeons showed that laser lipolysis and cellulite devices were the categories that most interested physicians who planned to purchase an AED device in 2010.* Under terms of the agreement Osyris USA, who currently sells the laser lipolysis device Lipotherme™, will be added to the current distribution network in the U.S. for products from Eleme Medical including the SmoothShapes® system. Additionally, Eleme Medical will provide certain sales support on certain Osyris product offerings, including Lipotherme.
Nancy Briefs, President and CEO of Eleme Medical, commented, "Osyris and Eleme Medical are premier aesthetic companies focused specifically on the body shaping segment. The addition of Osyris to the company's existing distribution network will provide greater geographic coverage in the United States. Combining the expertise of both teams is a strategic move to serve our physician partners more completely and increase revenues by offering one stop shopping for body shaping technologies that grow practices."
Osyris Medical USA is a subsidiary of the international leading medical laser company, Osyris Medical, headquartered in Lille, France. CEO Jaouad Zemmouri points out that the company has a large installed base of successful laser lipolysis users who are interested in novel body shaping protocols. "Offering SmoothShapes will allow Lipotherme users an opportunity to expand their practices by incorporating advanced pre and post laser assisted liposuction protocols that have been developed by some of the world's most influential plastic surgeons and dermatologists. This technology is a complement to our clinically and scientifically proven 980 wavelength devices for laser lipolysis."
Source: http://www.elememedical.com